News Hub | News Direct

Altais Launches New Multi-Specialty Independent Medical Practice in Riverside, CA

Altais

Healthcare services company Altais today announced the launch of a state-of-the-art multi-specialty medical group in Riverside, California. The new Altais Medical Group Riverside will provide a wide range of specialties from primary care and obstetrics and gynecology to interventional cardiology for community members in Riverside County beginning in February 2022. The nearly 11,000-square-foot facility is located at 4646 Brockton Ave, Riverside CA 92506. Leading up to the official opening of Altais Medical Group Riverside’s offices, prospective patients and others can visit www.amgriverside.com for more information. Visitors can also sign up online to receive important news and updates about the group via email or text, including when they can register as a new patient and schedule an appointment with a physician. The new Altais Medical Group Riverside is founded on a patient-centric model of care and provides comprehensive primary and specialty care. Services provided include everything from routine check-ups to specialized cardiac, obstetric, gynecologic, urologic and gastroenterological care. “The doctors and our healthcare teams at Altais Medical Group Riverside are all seasoned professionals with a deep commitment to serving the Riverside community,” said Rodolfo Saenz, M.D., an obstetrician / gynecologist at the new Riverside office. “Altais Medical Group Riverside patients will benefit from having multiple specialists under one roof. At the same time, we are fully committed to collaborating closely with the referral and hospital network already in place here in the Inland Empire. We are confident that new patients will appreciate the quality of care and patient-centric approach we provide.” Altais is a healthcare services company creating business models and integrated, scalable technology solutions that enhance the patient experience, improve health outcomes, reduce cost, and drive professional gratification among physicians. Altais invests directly in physician practices, clinics and related business models. In 2020, Brown & Toland Physicians, a network of more than 2,700 independent physicians in the San Francisco Bay Area, joined the Altais family of companies. Los Angeles’ Family Care Specialists, one of the largest community-based and Latinx-led private medical groups in California, joined Altais in December 2021. Altais also has two independent primary care clinics serving essential civic employees and educators in the Monterey-Salinas market. Recent studies show the greater Riverside community may have a deficit of up to 1,000 physicians to serve a growing Riverside County population of well over 2 million residents. Altais Medical Group Riverside aims to address that shortage by providing a new model of independent practice that, in time, can serve to attract more healthcare professionals to the region. “Altais is proud to launch this new medical practice group in Riverside County,” said Jeff Bailet, M.D., president and chief executive officer for Altais. “Over the past decade, the healthcare field generally and the Riverside community in particular – has experienced unprecedented levels of physician burnout and early retirements. Independent physicians have been overwhelmed by the administrative demands of maintaining their practices. Altais’ mission is to focus on reversing that trend and provide independent physicians with the business practices and technologies that help them not just endure but thrive during this difficult period and beyond. We are excited to bring that vision of medical practice vibrancy to reality in Riverside.” * * * ABOUT ALTAIS Altais is a healthcare services company that helps physicians and the clinical community maximize the health and well-being of their patients in an affordable and sustainable way. Altais has two divisions. Altais Clinical Services offers a range of affiliation and employment models for physicians and high-quality, affordable care for patients. Altais Health offers a broad platform of clinical support tools and technology, along with high-touch support. Ultimately, Altais seeks to enhance the vibrancy of physician practice and strengthen the heart of medicine – physicians connecting with patients and providing personalized, high-quality care. For more information about Altais, please visit www.altais.com. # # # Media, please note: For interview and image requests, please contact Robin Carr at (415) 971-3991 or altais@landispr.com. Contact Details Landis Communications Inc. Robin Carr +1 415-971-3991 altais@landispr.com Company Website https://altais.com/

January 12, 2022 06:00 AM Pacific Standard Time

Image

DealMaker announces new partnership with venture capital firm Wavemaker Labs

DealMaker

DealMaker, a data-driven capital raising technology platform, today announced a new partnership with Wavemaker Labs, a first-in-class global corporate venture studio and product development incubator focused on big data, artificial intelligence, and robotics. “We’re excited to formalize our work with Wavemaker through this partnership,” said Mike Werry, vice president of sales at Dealmaker, “Our collective success demonstrates the value our technology brings to organizations seeking to raise capital and illustrates how quickly our industry is changing. Progressive firms like Wavemaker are seeing the benefits of launching marketed, self-hosted raises for their clients.” Wavemaker will partner with DealMaker to help their clients raise additional capital after their own initial investment. The partnership began after Wavemaker achieved phenomenal success for their portfolio company, Miso Robotics, who leveraged the DealMaker platform to raise $30mm for their series C and D funding rounds. The partnership enables Wavemaker Labs to continue growing their portfolio companies and provide them with the right capital raising technology to scale effectively. Additionally, Wavemaker will continue to be a key advisory partner for DealMaker, using the insights from countless successful retail financings to shape future technology solutions. “Self-hosted raises equip our portfolio clients with expanded options to raise the capital they need to grow at scale while building community,” said Kevin Morris, CFO of Wavemaker Labs, “We are always looking to partner with disruptive companies like DealMaker. They are the best at what they do and their platform provides our clients with the tools they need for success.” +++ About DealMaker DealMaker is on a mission to create the most sophisticated capital markets tools on the planet, empowering capital to flow faster. It offers a suite of primary issuance, shareholder management, and capital raising solutions including investor ranking algorithms and data analytics tools to support all global private placements exemptions. Its innovative technology was designed to enable organizations to own and control exempt market raises to get the money they need, faster. DealMaker puts forward-thinking organizations in control to run streamlined, successful capital raises in one centralized platform. The company’s offices are located in Toronto, Canada and Tampa, Florida. Visit DealMaker.tech for more information. About Wavemaker Labs Wavemaker Labs is a food automation focused venture studio that builds disruptive technologies alongside corporate partners. Its lead investor, Wavemaker Partners, is a global venture capital fund with over $600 million of assets under management. Specializing in food and agriculture, Wavemaker Labs' goal is to help its partners think and execute like start-ups, and ultimately bring disruptive technology to market that advances their industry and business. Wavemaker has incubated and launched several robotics brands including Miso Robotics, Piestro, Bobacino and others. To learn more, visit https://www.wavemakerlabs.com. Contact Details Hot Paper Lantern Kristina Corso +1 908-278-6225 kcorso@hotpaperlantern.com Company Website https://www.dealmaker.tech/

January 12, 2022 09:00 AM Eastern Standard Time

Exchange Listing Client, Siyata Mobile Inc., Secures $20M in Financing

Exchange Listing

Exchange Listing LLC announced that its client, Siyata Mobile Inc., (NASDAQ: SYTA, SYTAW) (“ Siyata ” or the “ Company ”), a B2B global vendor of next generation Push-To-Talk over Cellular (PoC) devices and cellular booster systems, announced the pricing and closing of its underwritten public offering of 8,695,652 common shares (or pre-funded warrants to purchase common shares in lieu thereof) and accompanying warrants to purchase up to 8,695,652 common shares at a unit price of $2.30 for a total gross proceeds of $20,000,000. Maxim Group LLC acted as sole book-running manager for the offering. Siyata Mobile Inc. is a leading global developer and provider of cellular communications solutions for enterprise customers, specializing in connected vehicle products for professional fleets and first responders, marketed under the popular Uniden® Cellular brand. Siyata plans to use the gross proceeds from the offering, approximately $20 million before deducting underwriting discounts and commissions and other expenses to repay a portion of its outstanding senior secured convertible promissory note, and for general corporate purposes including working capital, growth strategies, research and development, sales and marketing. “This is the start of another exciting chapter for Siyata Mobile Inc. as it leads the development of increasingly sophisticated next generation Push-to-Talk over cellular devices and booster systems to the global market,” explains Peter Goldstein, CEO, Exchange Listing who also serves as Chairman of the Board of Directors of the Company. “Exchange Listing has provided incredible value with its extensive network and capital market guidance. With the closing of this financing, Siyata Mobile can advance its leadership position,” affirms Marc Seelenfreund, Founder and CEO, Siyata Mobile Inc. “We are poised for continued market growth as a result of this offering.” Exchange Listing provides companies with cost-effective and efficient direct access to one-stop solutions in the strategic planning and implementation of listing and uplisting on senior exchanges such as the Nasdaq or NYSE. Focusing on company-specific structuring to meet listing requirements, Exchange Listing serves as the primary point of contact with the exchange, investment bankers and lawyers throughout the listing process. With extensive experience in investment banking, securities law, corporate governance and business management, Exchange Listing and its strategic partners facilitate clients' listing and capital markets objectives. About Exchange Listing Exchange Listing provides growth companies with direct access to a one-stop solution in the strategic planning and implementation of listing on a senior exchange such as NASDAQ or NYSE in a cost effective and efficient process. We assist clients in going public whether through an initial public offering, listing from another marketplace, merger or direct offering. We serve as the primary point of contact with the exchange, investment bankers, lawyers and other service providers. Our founders, strategic partners and advisors are entrepreneurs with backgrounds in investment banking, securities law, corporate governance and business management and have served as officers and directors of public and private companies. We pride ourselves in taking a hands-on role with our clients throughout the listing process. For more information, please visit: www.exchangelistingllc.com or contact info@exchangelistingllc.com. Contact Details WantLeverage Communications Julie Livingston +1 347-239-0249 julie@wantleverage.com Company Website https://exchangelistingllc.com/

January 12, 2022 08:11 AM Eastern Standard Time

Foresight and SUNWAY-AI Collaborate to Commercialize Autonomous Technologies to the Chinese Agriculture Market

Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight”), an innovator in automotive vision systems, announced today the signing of a multiphase business cooperation agreement with SUNWAY-AI Technology (Changzhou) Co., Ltd. (“SUNWAY”), a global Chinese manufacturer of autonomous and unmanned intelligent vehicle products. The first phase will consist of a proof of concept (POC) project in which SUNWAY will test the QuadSight® vision prototype system and evaluate Foresight’s technology and its further potential integration into SUNWAY’s products and services. Upon successful evaluation, the parties intend to enter into a partnership agreement, including collaborative projects to develop and commercialize solutions focused on the Chinese agriculture and heavy machinery markets. SUNWAY designs and develops autonomous farms in China, among other projects, and intends to incorporate Foresight’s stereo technology into its unmanned autonomous agricultural vehicles. “This cooperation agreement in China with SUNWAY, a leading automotive-related manufacturer and integrator, opens the door to the growing market of automated machines and autonomous agriculture. This opportunity has the potential to enhance our footprint in the Chinese market by expanding our solution offerings. Our advanced 3D vision technologies, and particularly our thermal stereo vision system, address detection challenges that are caused by dust and fertilizer particles, harsh weather and lighting conditions, potentially bringing added value to automated machines and autonomous agriculture,” stated Haim Siboni, Chief Executive Officer of Foresight. About SUNWAY-AI Technology Sunway-AI Technology (Changzhou) Co., Ltd. focuses on research and development, design, manufacturing and sales of intelligent vehicle technology and products. The company's employees include technicians from the Institute of automation of the Chinese Academy of Sciences, Tsinghua Automobile Research Institute, BAIC and China automobile. SUNWAY’s technologies and products can be applied to autonomous vehicles, unmanned logistics and transportation vehicles and unmanned commercial vehicles. Commercial cooperation to date includes well-known domestic enterprises such as XCMG group, Liugong group and Shenzhen airport. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the business cooperation agreement between the parties, the potential for a future partnership agreement, that the agreement opens the door to the growing market of automated machines and autonomous agriculture and the potential for it to enhance its footprint in China. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 30, 2021, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third-party websites. About Foresight Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the Company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to diverse markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn. Contact Details Investor Relations Contact: Miri Segal-Scharia, CEO, MS-IR LLC +1 917-607-8654 msegal@ms-ir.com Company Website https://www.foresightauto.com/

January 12, 2022 08:10 AM Eastern Standard Time

McDade Products, LLC and G Medical Tests Secure Additional Purchase Order for $6.5 Million, Reflecting $3.5 Million Gross Margin, to be Delivered in Q1

G Medical Innovations Holdings

PITTSBURGH, PA – McDade Products, LLC and G Medical Tests and Services, a division of G Medical Innovations Holdings Ltd. (NASDAQ: GMVD), today announced an additional $6.5 million purchase order for two million COVID-19 PCR collection test kits. G Medical will be selling these units wholesale for $3.25 each, reflecting a gross profit of approximately $3.5 million. Additionally, G Medical expects to be paid an average of $85.00 per test through each patient’s insurance. “McDade is pleased to be expanding upon its existing purchase order so quickly and expects to be ordering a further seven million test kits in the next thirty days.” These orders seem to come at a pertinent moment with the Biden Administration recently requiring that private insurers pay for a minimum of eight COVID 19 test kits per person per month starting January 15 th. G Medical Tests and Services is delighted to provide McDade with current and future purchase orders. Visit https://www.mcdadegrp.com/ to place orders for the LiveNow PCR Collection Kits. About McDade Group Founded in 1994, McDade Group is a growing and dynamic sales, marketing, and distribution services company headquartered in Pittsburgh, PA. The company has expanded to provide solutions in distribution, category management, full-service merchandising, and consulting across the U.S. retail industry. Many of the world’s leading CPG manufacturers rely on the ability of McDade Group to build strong industry relationships and deliver services, insights, and expertise for hundreds of their products. Visit: https://www.mcdadegrp.com/ or LinkedIn: https://www.linkedin.com/company/mcdade-group/. About G Medical Innovations G Medical Innovations Holdings Ltd. is an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms. The Company’s solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes. The Company’s current product lines consist of its Prizma medical device (or Prizma), a clinical grade device that can transform almost any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (or ECG) data continuously, including its QT Syndrome Prolongation Detection Capabilities Patch. In addition, the Company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous and real time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (or IDTF) monitoring services and private monitoring services. Visit https://gmedinnovations.com/. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on G Medical’s and McDade Products’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of G Medical and McDade Products could differ materially from those described in or implied by the statements in this press release. For example, G Medical is using forward-looking statements when it discusses delivery of purchase orders and anticipated gross profits. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in G Medical’s prospectus filed pursuant to Rule 424(b)(4), filed with the Securities and Exchange Commission (“SEC”) on June 28, 2021, and in any subsequent filings with the SEC. Except as otherwise required by law, the companies undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. G Medical and McDade Products are not responsible for the contents of third-party websites. Investor Relations CONTACT: G Medical Innovations Kobi Ben-Efraim, CFO +972 8-958-4777 service@gmedinnovations.com Contact Details Kobi Ben-Efraim, CFO +972 8-958-4777 service@gmedinnovations.com Company Website https://gmedinnovations.com/

January 12, 2022 07:00 AM Eastern Standard Time

VinFuture Award Ceremony Week – A gathering of global science quintessences

Vingroup

HANOI, VIETNAM - Media OutReach - 11 January 2022 - the VinFuture Foundation has officially announced the agenda for academic events during the inaugural VinFuture Sci-Tech Week on January 18-21, 2022, in Hanoi, Vietnam. These are international events that will see the arrival of leading scientists to Vietnam in order to work together for the mission of science to practically and effectively serve humanity. The VinFuture Sci-Tech Week is an important event that attracts the attention of thousands of scientists, policymakers, and entrepreneurs around the world. For the first time ever, the world-renowned influential scientists will gather in Vietnam to take part in the VinFuture Sci-Tech Week’s 4 main activities: The Conversation with the Prize Council and Pre-screening Committee; the "Science for life" Symposium; the inaugural VinFuture Award Ceremony; and the Scientific Dialogue with the inaugural VinFuture Prize Laureates. The event series begins with the Conversation with the Prize Council and Pre-screening Committee, taking place on January 18 th, 2022, with the participation of outstanding scientists including the Chair of the VinFuture Prize Council - Professor Sir Richard Henry Friend – University of Cambridge, 2010 Laureate of the Millennium Prize in Physics; Professor Gérard Mourou – École Polytechnique (France), 2018 Nobel Prize Laureate in Physics; and several other leading scientists from the VinFuture Prize Council and Pre-Screening Committee. At the event, they will share their passion and discuss the achievements and sacrifices made throughout their scientific journey. The event aims to inspire the love for research and open up possibilities for Vietnamese scientists to approach international projects around the world. Following this first event, the "Science for life" Symposium will be held on January 19 th, 2022 with the participation of leading scientists, such as Professor Sir Richard Henry Friend, Professor Gérard Mourou, Professor Antonio Facchetti, Professor Sir Konstantin (Kostya) S. Novoselov, Professor Jennifer Tour Chayes; leaders from the Ministry of Health, the Ministry of Science and Technology and the Ministry of Information and Communication, along with business leaders from prestigious domestic and international corporations. Notably, the event will see the attendance of guest speakers who have played an important role in humanity's fight against Covid-19 globally: Professor Katalin Kariko; Professor Drew Weissmen and Professor Pieter R Cullis - the scientists behind mRNA technology for Covid-19 vaccines; Doctor Quarraisha Abdool Karim and Doctor Salim Abdool Karim - epidemiologists with outstanding contributions to combating HIV and other contagious diseases. The three sessions of the symposium will each be 90 minutes in length and address three critical themes: the Future of Energy, the Future of Artificial Intelligence, and the Future of Global Health. Each session will focus on future trends as well as projections of key changes in people’s lives with the increasing intervention of science and technology. These topics are pressing issues at the center of the scientific community's attention, accounting for most nominations in this year’s VinFuture Awards. With the meaningful gathering of eminent scientists, policymakers and leading entrepreneurs, the symposium will promote scientific and technical support to create new breakthroughs, contributing to improving people’s lives and realizing sustainable development for our planet and future generations. The events are centered around the VinFuture Award Ceremony, held in the evening of January 20 th at the Hanoi Opera House. This will be a formal ceremony with the participation of Vietnamese government officials, world-leading scientists - recipients of prestigious scientific awards such as the Nobel Prize, the Millennium Technology Prize, the Turing Award,... Following the ceremony will be a outstanding performance exclusively created for the event, featuring two international music stars who have won various prestigious awards: John Legend and Dang Thai Son. The Award Ceremony will be streamed live on VTV and international platforms for science and technology. The closing event of the Sci-Tech Week is the Scientific Dialogue with the inaugural VinFuture Prize Laureates, which will take place on the morning of January 21 st, 2022 at VinUniversity (Hanoi). Held just after the award announcement night, this event serves to inspire the public with the first generation of VinFuture Prize Laureates’ sharing about their lives, their motivations, and their research journeys to the successful creation of their award-winning inventions. Along with the main events, VinFuture will also host The Sci-Tech Week with a series of exciting academic workshops, exhibition, public lectures, and so on, that is expected to attract the participation of scientists and the general public. The Sci-Tech Week and VinFuture Award Ceremony will take place annually, contributing to positioning Vietnam as a new destination for global science and technology, while creating the foundation for the multilateral connection between Vietnam’s scientific and technological community and the world. VinFuture expects to tap into new opportunities for the intellectual connections between scientists, policy makers and entrepreneurs, promoting healthy commercialization, and suggesting new research ideas with high applicability, as to fulfill VinFuture's mission of serving humanity. I/ TIMELINE OF THE VINFUTURE SCIENCE WEEK Conversation with the Prize Council and Pre-screening Committee Time: 9AM - 12:30PM, January 18 th 2022 Location: Almaz International Conference Center, Vinhomes Riverside, Long Bien Dist., Hanoi. "Science for Life" Symposium Time: 9AM – 4:30PM, January 19 th 2022 Location: Almaz International Conference Center, Vinhomes Riverside, Long Bien Dist., Hanoi. The Inaugural VinFuture Award Ceremony Time: 8PM, January 20 th 2022 Location: Hanoi Opera House, 1 Trang Tien Street, Hoan Kiem Dist., Hanoi. Scientific Dialogue with the inaugural VinFuture Prize Laureates Time: 9AM - 12PM, January 21 st 2022 Location: VinUniversity, Vinhomes Ocean Park, Gia Lam Dist., Hanoi. II/ LIST OF SCIENTISTS PARTICIPATING IN VINFUTURE SCI-TECH WEEK 1. Conversation with Members of the VinFuture Prize Council and Pre-Screening Committee on January 18th, 2022 - Professor Sir Richard Henry Friend - University of Cambridge, United Kingdom, 2010 Laureate of the Millennium Technology Prize in Physics for his work on plastic electronics, one of the world's most influential physicists, knighted for “Services to Physics” in 2003 by the Queen of England - Professor Gérard Mourou - École Polytechnique, Palaiseau, France, 2018 Nobel Laureate in Physics for his work on generating ultrashort high-intensity laser pulses without destroying the amplifying material, one of the leading scientists in electrical engineering and lasers in the world. - Other members of the VinFuture Prize Council and Pre-Screening Committee 2. “Science for Life” Symposium on January 19th, 2022 “Future of Energy”: The session will discuss the most critical alternative energy sources of the future and how to make energy cleaner, cheaper and accessible to the vast majority of people around the world. Professor Sir Richard Henry Friend Professor Gérard Mourou Professor Antonio Facchetti - Professor of Chemistry at Northwestern University, and Chief Technology Officer at Flexterra, owner of over 160 patents and author of over 430 academic papers. He is one of the scientists with special ability to bring innovations into practical business and applications, and energy production. Professor Thuc-Quyen Nguyen - Director of the Center for Polymers and Organic Solids (CPOS) at the University of California, Santa Barbara (UCSB). She is among the Top 1% Most Cited Researchers in Materials Science by Clarivate Analytics and Thomson Reuters from 2015 - 2018. Professor Sir Konstantin (Kostya) S. Novoselov - University of Manchester, 2010 Nobel Laureate in Physics for his breakthrough experiment in the super-material of graphene. He is one of the world's most influential scientists and most cited scientists and well-known for being one of the youngest Nobel Physics Laureates, receiving the honor at the age of. “Future of Artificial Intelligence”: Thesession will discuss the impact of AI on people's lives, how to create a competitive advantage, close the gap between countries as well as potential risks or moral issues, that need to be considered. Dr. Padmanabhan Anandan - Founder of US-based AI Matters Advisors LLC. He is also the former Founder and Managing Director of Microsoft Research India, Vice President of Adobe Research with his research in computer vision, visual motion analysis, video surveillance, and 3D scene modeling. Professor Albert P. Pisano - Dean of the Jacobs School of Engineering at the University of California San Diego, Member of the National Academy of Engineering (United States). He is the co-inventor of over 20 patents and co-author of over 300 archival publications in microelectromechanical systems (MEMS). Professor Vu Ha Van - Professor of Mathematics at Yale University, United States, Scientific Director of VinBigData. He is the pioneer scientist in researching and developing high-tech products. He received the Polya Prize from the Society of Applied and Industrial Mathematics. Doctor Bui Hai Hung - Founding Director of VinAI. He is an expert in machine learning and artificial intelligence, owner of 10 patents, with nearly 100 works published in popular IT & AI journals. Prior to joining VinAI, he had held important positions at Google DeepMind, Adobe Research, AI Center, and SRI International. Professor Jennifer Tour Chayes - Managing Director of 3 Microsoft Research interdisciplinary labs in Cambridge, New York and Montreal; Dean of the School of Information at UC Berkeley; Member of the National Academy of Science (United States). Doctor Xuedong David Huang - Chief Technology Officer, Microsoft Corporation, owner of 170 patents who plays an important role in the research of robotic visual, audio and comprehension capabilities to support humans in their daily lives. “Future of Health”: The session will discuss the advancement of medicine in life, the responsibilities of different stakeholders in the healthcare sector, and especially the most critical issues surrounding humanity's battle against Covid pandemic and its variants. Professor Pieter Rutter Cullis - Founding Director of Centre for Drug Research and Development (CDRD), University of British Columbia. He is the pioneering scientist in genetic treatment using LNP technology. Professor Katalin Kariko - Senior Vice President of BioNTech. She is well-known for her contribution in mRNA technology and mRNA COVID-19 vaccines. She has received the Princess of Asturias Award, the Vilcek Prize for Excellence in Biotechnology, the Breakthrough Prize in Life Sciences, and Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research. Professor Salim Safurdeen Abdool Karim - Pro Vice-Chancellor at the University of KwaZulu-Natal, South Africa; Head of the South African Ministerial Advisory Committee on COVID-19 and South Africa’s response to Omicron. Professor Quarraisha Abdool Karim, Associate Scientific Director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), Vice President of the African Academy of Sciences, Chair of the South African National AIDS Council Prevention Technical Task Team. She is particularly well-known for her work in AIDS research, with her inventions of topical gels to reduce HIV transmission among young women and girls in Africa. She received the L'Oréal-UNESCO Award for Women in Science for her success in helping African women fight against HIV and improve their lives. Professor Drew Weissman - Director of Vaccine Research, Infectious Diseases Division at Perelman School of Medicine, University of Pennsylvania. He is a pioneer in the field of Immunology, best known for his basic scientific research to develop safe vaccines for various diseases. He has been honored with the Princess of Asturias Award, Breakthrough Prize in Life Sciences, Lewis S. Rosenstiel Award, Lasker-DeBakey Clinical Medical Research Award, Louisa Gross Horwitz Award and Special Achievement Award of the National Institutes of Health (United States). Professor Robert C. Green, Founding Director of Brigham Preventive Genomics Clinic, Harvard University. He is one of the 25 most influential scientists worldwide in precision medicine. Professor Stephen Ronal Quake, Stanford University. Co-chair of Biohub. He is well-known for biomeasurements, especially for biomolecular works, biological drugs as well as genomic structure and gene sequencing techniques. About the VinFuture Prize The VinFuture Prize Foundation, established on International Solidarity Day, December 20th, 2020, is an independent and non-profit organization in Vietnam founded by billionaire Pham Nhat Vuong and his wife.The Foundation was established with the vision and mission of catalyzing meaningful changes in the everyday lives of millions of people. The Foundation's core activity is awarding the annual VinFuture Prize for breakthrough scientific and technological innovations that have made or have the potential to create meaningful changes in people's lives.A total of four prizes are awarded by the VinFuture Prize Foundation every year, consisting of the VinFuture Grand Prize valued at US$3 million - one of the largest ever annual prizes globally. VinFuture also awards three Special Prizes, each valued at US$500,000, dedicated to female innovators, developing country innovators, and innovators with outstanding achievements in emerging fields.In addition, the Foundation will conduct many activities to accomplish its mission, such as funding research projects, collaborating in academic development, and promoting STEM education. Contact Details Vingroup +84 24 3974 9999 v.chidqd@vingroup.net Company Website https://www.vingroup.net/en

January 11, 2022 10:30 AM Eastern Standard Time

Image

Industrial Defender 7.4 Centralizes Data Collection, Offers Customized Risk Calculations to Secure OT Environments

Industrial Defender

Industrial Defender, an operational technology (OT) security pioneer, today announced updates to its leading cybersecurity platform to help organizations better secure their OT environments. Industrial Defender version 7.4 offers streamlined data collection capabilities, enhanced APIs and more personalized risk score calculations so teams can better prioritize threats. Amid the rising number of cyberattacks targeting critical infrastructure, organizations are increasingly looking for more streamlined solutions that will better secure their OT environments to ensure business continuity. With the launch of Industrial Defender 7.4, organizations can more easily collect and share data across silos via the Industrial Defender Collector, which combines the functionality of active and agentless endpoint monitoring and a network intrusion detection system (NIDS) into a single appliance. Enhanced integrations with partners like Splunk also allow teams to reduce MTTR for cyberthreats in OT environments with centralized threat detection and response. “Data is the lifeblood of a business’ security strategy. Without a wide-ranging data set that includes information from all different facets of the organization – including OT environments– it is nearly impossible to get a proper view of the potential threats putting the business at risk,” said Peter Lund, Vice President of Product Management, Industrial Defender. “With our latest updates, users can use OT data more holistically to better understand where their weaknesses lie and calculate more personalized endpoint risk scores that’ll help them prioritize what really matters.” As Industrial Defender continues to enhance and expand its OT data collection and integration capabilities, Industrial Defender Automation Systems Manager (ASM) is now Industrial Defender Central Manager (IDCM) to better reflect the company’s focus on centralizing OT endpoint and network data management. Additional updates and key features for Industrial Defender 7.4 include: Industrial Defender Collector: Combines active, agentless and passive asset inventory methods into a single sensor to streamline and centralize OT data collection. Per Endpoint Risk Calculations: Allows customization of risk profiles on a per asset basis using threat vectors such as unpatched vulnerabilities, security events and health status. Enhanced APIs: Supports complete data exchange via integrations with enterprise tools, including Splunk's machine learning models. Secure PCAP Replays: Safely replays network traffic within the IDCM to avoid potential disruptions from data overflow onto the OT network. Industrial Defender version 7.4 will be available to all customers on January 11, 2022. For more information, visit https://www.industrialdefender.com/ot-cyber-risk-management/. About Industrial Defender Since 2006, Industrial Defender has been solving the challenge of safely collecting, monitoring, and managing OT asset data at scale, while providing cross-functional teams with a unified view of security. Their specialized solution is tailored to complex industrial control system environments by engineers with decades of hands-on OT experience. Easy integrations into the broader security and enterprise ecosystem empower IT teams with the same visibility, access, and situational awareness that they’re accustomed to on corporate networks. Learn more at www.industrialdefender.com. Contact Details Industrial Defender Corey Burke +1 904-643-2650 cburke@industrialdefender.com Company Website https://www.industrialdefender.com

January 11, 2022 10:00 AM Eastern Standard Time

Velocity Global welcomes LPGA Tour Stars Lexi Thompson and Albane Valenzuela as brand ambassadors

Velocity Global

Velocity Globa l, the leading provider of global talent solutions, welcomed 11-time LPGA Tour champion, Lexi Thompson, and former Stanford collegiate standout and rising LPGA star, Albane Valenzuela, as global golf brand ambassadors. Both 2021 Olympians will display the Velocity Global logo on their hats throughout the 2022 and 2023 seasons. Thompson and Valenzuela join six-time PGA TOUR champion and 2021 DP World Tour BMW PGA champion, Billy Horschel, and four-time Advocates Pro Golf Association (APGA) Tour champion, Kevin Hall, as global brand ambassadors for Velocity Global. “Studies are backed by stories from our clients and employees on how important ‘work anywhere’ is to women, and it was time for us to welcome two of the best professionals in the world of golf to help us tell that story,” said Rob Wellner, Velocity Global chief revenue officer. “Lexi and Albane carry our message to a global audience that embraces the opportunity to work for anyone, anywhere. We can’t wait to support both of them as they compete around the world.” Thompson is one of the biggest stars on the LPGA Tour and across all of sports, and has been a top performer since she turned pro in 2010 at the age of 15. She owns 14 worldwide professional victories, including one major championship, and she is currently ranked 12th on the Rolex Rankings. She has represented the U.S.A. five times at the Solheim Cup and twice as an Olympian in Rio and Tokyo. She turned her passion for fitness and self-care into businesses as an entrepreneur with her LEXI Skin and LEXI Fitness brands. “I’m blessed to apply my talents all over the world, and that’s what Velocity Global makes possible for other professions,” said Thompson. “They help people work for anyone, anywhere around the world. And as an entrepreneur, I love their passion for helping businesses grow. Velocity Global is a perfect fit and I’m proud to represent them.” Valenzuela is truly a global citizen of the game as she was born in New York, moved to Mexico at a young age, and later grew up in Switzerland. Her father is from Mexico and her mother is from France, which led to her fluencies in English, French, Spanish, and German. She had a historic collegiate career at Stanford University where she competed in 11 major championships as an amateur, was the 2019 Pac-12 Golfer of the Year, and was a two-time runner-up in the U.S. Women’s Amateur. Albane turned pro in 2020 and represented Switzerland in the last two Olympic games. She uses her platform on the LPGA Tour to support her other passion, Alexis for Autism, a foundation established with and named after her brother that raises funds for associations, foundations, and medical research for autism. “I grew up in a family that knows what it means to be global citizens, and I found a partner in Velocity Global that aligns with that world view,” said Valenzuela. “Golf is truly a global sport. To achieve success, you must perform against anyone, anywhere. That’s exactly what Velocity Global enables for businesses and talent.” Thompson and Valenzuela begin their 2022 seasons at the Gainbridge LPGA at Boca Rio on January 27. About Velocity Global Velocity Global accelerates the future of work beyond borders. Its global work platform simplifies the employer and employee experience to employ any talent anywhere with just a click through its proprietary cloud-based workforce management technology, backed by personalized expertise and unmatched global scale. As the largest global Employer of Record (also known as International PEO) in 185 countries and all 50 United States, more than 1,000 brands rely on Velocity Global to build global teams without the cost or complexity of setting up foreign legal entities or state registrations. The company offers additional services including Independent Contractor Compliance to assess a workforce, and Agent of Record (AoR) to streamline payments to contractors. Velocity Global was named a “Leader” in Global Employer of Record services by prominent analyst firm NelsonHall. Founded in 2014, the company has hundreds of employees across six continents. For more information visit velocityglobal.com. Contact Details Velocity Global John Hall +1 720-650-4348 news@velocityglobal.com For Lexi Thompson Brett Falkoff, VP, Golf, GSE Worldwide bfalkoff@gseworldwide.com For Albane Valenzuela Jon Heaton, VP, Excel Sports Management jheaton@excelsm.com Company Website https://velocityglobal.com/

January 11, 2022 07:01 AM Mountain Standard Time

Image

Biomedical AI entrepreneur Prof. Amir Geva appointed CSO of SleepX

Appyea

World renowned machine learning and bio-feedback expert joins company to execute and lead the development of DreamIT – the company’s patented solution integrating its proprietary AI technology in a wearable data driven wristband to treat sleep apnea and snoring. SleepX, a subsidiary of AppYea (OTC: APYP) focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announced today the appointment of Biomedical AI entrepreneur Prof. Amir Geva, as its chief science officer. Prof. Geva is a world-renowned expert in the field of machine learning, with over 25 years of business leadership experience as the founder and R&D teams leader of biomedical AI companies Elminda, InnerEye and WideMed. He brings over 40 years of deep AI research, serving today as the Head of the Biomedical Signal Processing and Machine Learning Lab and as Professor at the Electrical and Computers Engineering Department at Ben Gurion University of the Negev in Israel. As of today, Prof. Geva had published 62 scientific articles, and he is Senior Member at the Biomedical Engineering and Computers of the IEEE. In the past he had served also as consultant to the Israeli Air Force and Elbit on bioelectrical signal processing. He is DSc in Biomedical Engineering from the Technion Israel Institute of Technology, and formerly a Major at the Israeli Navy. "SleepX’ is the right solution many had been waiting for", Prof. Amir Geva commented. "The company has introduced a revolutionary combination of sensor technology, data analysis and machine learning to take on the challenge sleep-training for adults and improving people’s sleep and general wellbeing. I look forward to working with the team to complete the development of the company’s product and realize its market potential." SleepX is an Israeli research and development company recently acquired by AppYea. The company had developed a unique product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents and the company plans to start serial production in 2022. The company currently focuses its activities on the development and commercialization of its flagship product DreamIT. "We are honored to have a world expert in bio-feedback and AI such as Prof. Geva joining us to lead the development of our product’s brain analysis capabilities and advance the execution of our go-to-market strategy to realize the company’s business plan", said Boris (Bary) Molchadsky, President and CEO of SleepX, and Chairman at AppYea. Contact Details AppYea Inc. Asaf Porat info@appyea.com Company Website http://www.appyea.com

January 11, 2022 08:24 AM Eastern Standard Time

Image